aponvie

Generic: aprepitant

Labeler: heron therapeutics, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name aponvie
Generic Name aprepitant
Labeler heron therapeutics, inc.
Dosage Form EMULSION
Routes
INTRAVENOUS
Active Ingredients

aprepitant 32 mg/4.4mL

Manufacturer
Heron Therapeutics, Inc.

Identifiers & Regulatory

Product NDC 47426-401
Product ID 47426-401_40d678ae-e92d-46e3-aaeb-ce49e336cfb5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA216457
Listing Expiration 2026-12-31
Marketing Start 2023-03-06

Pharmacologic Class

Established (EPC)
substance p/neurokinin-1 receptor antagonist [epc]
Mechanism of Action
neurokinin 1 antagonists [moa] cytochrome p450 3a4 inhibitors [moa] cytochrome p450 2c9 inducers [moa] cytochrome p450 3a4 inducers [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 47426401
Hyphenated Format 47426-401

Supplemental Identifiers

RxCUI
2631783 2631788
UNII
1NF15YR6UY
NUI
N0000010262 N0000175786 N0000182141 N0000185507 N0000185506

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aponvie (source: ndc)
Generic Name aprepitant (source: ndc)
Application Number NDA216457 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 32 mg/4.4mL
source: ndc
Packaging
  • 10 VIAL, GLASS in 1 CARTON (47426-401-10) / 4.4 mL in 1 VIAL, GLASS (47426-401-01)
source: ndc

Packages (1)

Ingredients (1)

aprepitant (32 mg/4.4mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "40d678ae-e92d-46e3-aaeb-ce49e336cfb5", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "unii": ["1NF15YR6UY"], "rxcui": ["2631783", "2631788"], "spl_set_id": ["d1b111eb-659a-496b-a86a-8f0fa370f147"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Heron Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, GLASS in 1 CARTON (47426-401-10)  / 4.4 mL in 1 VIAL, GLASS (47426-401-01)", "package_ndc": "47426-401-10", "marketing_start_date": "20230306"}], "brand_name": "APONVIE", "product_id": "47426-401_40d678ae-e92d-46e3-aaeb-ce49e336cfb5", "dosage_form": "EMULSION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "47426-401", "generic_name": "APREPITANT", "labeler_name": "Heron Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "APONVIE", "active_ingredients": [{"name": "APREPITANT", "strength": "32 mg/4.4mL"}], "application_number": "NDA216457", "marketing_category": "NDA", "marketing_start_date": "20230306", "listing_expiration_date": "20261231"}